| LINC00511 |
Upregulated |
TNM stages, promotes pro-proliferation, pro-migration |
(96) |
| LINC01133 |
Upregulated |
Low survival periods, metastasis |
(97) |
| FAM201A |
Upregulated |
Predictor of distance metastasis, and poor survival |
(98) |
| CACNA2D3-AS1, POU6F2-AS2 |
Upregulated |
Prognostic biomarker in overall survival |
(101) |
| TTTY16 |
Downregulated |
Prognostic biomarker in overall survival |
(101) |
| lncRNA SOX2-OT |
Up-regulated |
tumor size, TNM stage, and lymph node metastasis |
(108) |
|
AL161431.1, LINC02389, APCDD1L-DT |
– |
LUSC prognosis |
(109) |
| VPS9D1-AS1 |
Up-regulated |
Prognostic biomarker in overall survival |
(110) |
| MALAT-1 |
Upregulated |
Prognostic biomarker in overall survival |
(111) |
| LINC01031, LINC01088, LINC01931 |
Upregulated |
Poor survival |
(112) |
| GATA6-AS1, TBX5-AS1, FEZF1-AS1, SFTA1P, LINC00968 |
Up-regulated |
Diagnosis and prognosis associated |
(113,114) |
| FAM83A-AS1, MIR31HG, MIR99HG |
– |
Prognostic biomarker in overall survival |
(115) |
| LINC00519 |
Upregulated |
Disease free survival |
(116) |
